Clinical characteristics and outcomes of Hodgkin Lymphoma: A single institution retrospective cohort study.
Treatment response and platelet counts predict survival in a Middle Eastern lymphoma cohort, confirming prognostic markers work across populations.
A single-institution retrospective cohort of 257 Hodgkin lymphoma patients at a Jordanian center (2002-2022) identifies poor treatment response and low platelet count as independent predictors of inferior survival. These findings replicate known prognostic factors in a regional real-world setting with limited therapeutic resources, contributing to descriptive epidemiological data for the Middle Eastern patient population.
What the study was
- Study design
- single-institution retrospective cohort study
- Population
- Hodgkin lymphoma patients, single Jordanian institution (n=257, 2002-2022)
- Sample size
- 257
- Category
- Public Health
- Maturity
- Validated
- Journal
- PloS one
Why it surfaced
Routine single-institution HL outcomes study; known predictors confirmed in regional cohort; no novel findings or therapeutic implications; included for completeness of T1 coverage.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.